Synergistic enhancement of cancer therapy using a combination of carbon nanotubes and anti-tumor drug

Phase II trial of estramustine phosphate and oral etoposide in patients with hormone-refractory prostate cancer

(2009) G. Spitaleri et al.   ANNALS OF ONCOLOGY

Poly(lactide)–vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel

(2009) Si-Shen Feng et al.   BIOMATERIALS

Drug Delivery with Carbon Nanotubes for In vivo Cancer Treatment

(2008) Z. Liu et al.   CANCER RESEARCH

Newer Cytotoxic Agents: Attacking Cancer Broadly

(2008) B. A. Teicher   CLINICAL CANCER RESEARCH

Assessment of DNA double-strand breaks and γH2AX induced by the topoisomerase II poisons etoposide and mitoxantrone

(2008) Daniel J. Smart et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

Quantum Dots as Multimodal Photoacoustic and Photothermal Contrast Agents

(2008) Evgeny V. Shashkov et al.   NANO LETTERS

Carbon nanotubes filled with a chemotherapeutic agent: a nanocarrier mediates inhibition of tumor cell growth

(2008) Silke Hampel et al.   Nanomedicine

Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy

(2008) Z. Liu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Functionalized Carbon Nanotubes in Drug Design and Discovery

(2007) Maurizio Prato et al.   ACCOUNTS OF CHEMICAL RESEARCH

Etoposide-resistant HT-29 human colon carcinoma cells during glucose deprivation are sensitive to piericidin A, a GRP78 down-regulator

(2007) Ji-Hwan Hwang et al.   JOURNAL OF CELLULAR PHYSIOLOGY